1 / 6

Steven Cantor SAC Consulting Group, Ltd.

Steven Cantor SAC Consulting Group, Ltd. traveled to the Sun Yat-sen Medical University in Guangzhou, China to conduct due diligence on a non invasive device for the treatment of heart disease

sten19
Download Presentation

Steven Cantor SAC Consulting Group, Ltd.

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Steven Cantor SAC Consulting Group, Ltd.

  2. Steven Cantor was the founder, Chairman of the Board, and CEO of Vasomedical, Inc., developer of an innovative heart disease device used in prestigious medical centers around the world, such as The Mayo Clinic, and The Miami Heart Institute. Vasomedical Inc. provides superior medical products and services that address unmet clinical needs in the management of patients with heart disease

  3. Technological and clinical advancement led to the development of EECP - Enhanced External Counterpulsation, the therapeutic systems exclusively designed and manufactured by Vasomedical with sequential pneumatic compression to increase retrograde diastolic flow, venous return and systolic unloading, greatly improve the ease of use, patient safety and clinical effectiveness.

  4. Steven Cantor SAC Consulting Group, Ltd. traveled to the Sun Yat-sen Medical University in Guangzhou, China to conduct due diligence on a non invasive device for the treatment of heart disease that subsequently received United States Food and Drug Administration (FDA) approval and was launched worldwide and described as a major medical breakthrough in heart disease. Known as the Enhanced External Counter Pulsation (EECP) treatment for coronary artery disease it is used worldwide in over 1,000 centers including at the Mayo Clinic, the Cleveland Clinic, Beth Israel Medical Center, Johns Hopkins, the Ochsner Foundation Hospital, The Miami Heart Institute, Scripps Center for Integrative Medicine and the Texas Heart Institute.

  5. Steven Cantor SAC Consulting Group, Ltd. wanted to do more for more people and he left his day to day operational positions at the Company he founded to pursue other interests in the healthcare industry with the Former President of Merck International joining as Chairman of the Board and CEO, the positions Mr. Cantor held during his tenure.

  6. Thanks Steven Cantor SAC Consulting Group, Ltd.

More Related